Pharmacies — US Industry Report
Official NAICS classification: Pharmacies and drug stores (44611)
The pharmacies and drug stores industry in the United States generated an estimated ~$400.8B in annual revenue across 41.8K establishments employing 691.2K workers (Census Bureau). This 32-page report analyzes industry performance, competitive dynamics, and delivers 5-year growth forecasts.
Industry Snapshot
- ▸Pharmacy closures accelerating while payroll expenses contract amid revenue growth
- ▸Staffing levels rising substantially alongside declining real compensation per employee
- ▸Labor productivity gains outpacing historical performance across the sector
- ▸Payroll represents a minority share of revenue, signaling profit concentration elsewhere
Table of Contents
1.Executive Summaryp. 4
Key takeaways, industry definition, and current state overview. Covers the industry's scope, principal activities, NAICS classification context, and a concise snapshot of where the industry stands today. Reading this alone gives decision-makers the high-level picture they need before diving into data-backed chapters.
2.Industry Performancep. 6
Historical performance analysis covering establishments, employment, and payroll (2012-2025). Examines what has driven industry performance in recent years, how the industry has responded to macroeconomic cycles, and which operating conditions have shaped revenue and labor dynamics. Includes source-cited tables and year-by-year data points.
3.Industry Forecastp. 9
5-year projections (2026-2030) with base case, bull case, and bear case scenarios. Each scenario combines historical trends, macroeconomic indicators from FRED, and industry-specific signals. Addresses questions on expected trajectory, forecast risk, downside drivers, and the assumptions behind each scenario.
4.Industry Outlookp. 12
Growth drivers, risk factors, and external environment analysis. Unpacks the forces that will shape the industry over the forecast horizon — demographic shifts, regulatory changes, technology adoption, and cyclical exposure. Frames both the upside opportunities and the structural risks operators and investors should weigh.
5.Competitive Landscapep. 15
Market structure, concentration, barriers to entry, and competitive dynamics. Describes how the industry is structured between incumbents and entrants, typical competitive strategies, and what separates successful operators. Standard-tier reports add the official CR4, CR8, CR20, CR50 and HHI from the Census Economic Census, plus the largest public operators named from SEC EDGAR 10-K filings.
6.Operating Conditionsp. 18
Cost structure, labor requirements, technology factors, and the regulatory environment. Examines where operators spend, how sensitive margins are to input costs, what workforce and technology investments are typical, and which compliance and regulatory constraints shape day-to-day operations and long-term planning.
7.SWOT Analysisp. 20
Strengths, weaknesses, opportunities, and threats — each supported by concrete evidence from the underlying data. Moves beyond generic bullet points by tying each SWOT element to specific metrics, structural trends, or external forces identified elsewhere in the report. Useful for strategic planning and risk assessment.
8.Geographic Breakdownp. 23
Regional market concentration, wage dynamics, and emerging geographic opportunities. Breaks establishments, employment, and payroll down by state and region, identifies where the industry is densest, where it is growing fastest, and how local labor markets and wage levels differ. Standard-tier and higher includes state-level tables.
9.Major Industry Playersp. 27
The largest public operators in the industry, named from their SEC EDGAR 10-K filings, with enterprise revenue and segment context. Sits alongside the official Census Economic Census concentration figures (CR4, CR8, CR20, CR50, HHI) so the named players can be read against the measured structure of the whole industry, public and private.
Report Preview

Low-resolution overview of all 32 pages
Want to see a full report before you buy?
Download a free sample report →Industry Analysis
The Pharmacies and drug stores industry (NAICS 44611) encompasses 41.8K establishments in the United States employing 691.2K workers, generating an estimated ~$400.8B in annual revenue (Census Bureau). Classified within Retail Trade, the industry is positioned in a mature phase of its life cycle.
This report examines historical performance trends (2012-2025), competitive structure, geographic distribution, and provides a 5-year outlook (2026-2030) with growth drivers, risk factors, and industry-specific SWOT analysis.
Products & Services
Key service categories in the Pharmacies and drug stores industry.
Who Uses These Reports
Trusted by professionals who need verified federal data to make decisions
Investors & PE Firms
Size markets, validate deal theses, and benchmark targets with verified federal data before committing capital
Consultants & Advisors
Deliver data-backed recommendations to clients with sourced and cited industry metrics — Census, BLS, and FRED
Founders & Operators
Validate market entry, benchmark against industry averages, and present credible data to investors and boards
Corporate Strategy Teams
Support expansion planning, M&A due diligence, and executive reporting with NAICS-classified industry data
Top Questions Answered
What is the market size of the Pharmacies and drug stores industry?
The Pharmacies and drug stores industry generated ~$323.1B in revenue (US Census Economic Census, 2022, on the NAICS 2017 definition (Census comparative statistics)). Full analysis available in report.
How fast is the Pharmacies and drug stores industry growing?
The industry has followed a moderate expansion trajectory in recent years. Employment rose over 2019-2023, which indicates that the sector has continued to add workers rather than contract. Full analysis available in report.
What is the outlook for the Pharmacies and drug stores industry?
The industry is projected to continue its growth trajectory, extending the direction seen in the historical record. Full analysis available in report.
How does the Census define the Pharmacies and drug stores industry (NAICS 44611)?
The Census Bureau defines NAICS 44611 under the 2017 classification as follows: "This industry comprises establishments known as pharmacies and drug stores engaged in retailing prescription or... Full analysis available in report.
How many pharmacies and drug stores operate in the United States?
There were 41.8K establishments in the industry (Census CBP, 2023), employing 691.2K people (Census CBP, 2023). Full analysis available in report.
How competitive is the Pharmacies and drug stores industry?
The industry carries a Moderate size label, which reflects average establishment size rather than a concentration ratio. Full analysis available in report.
Have wages in the Pharmacies and drug stores industry kept up with inflation?
It depends on the measure, and the report gives both. On the BLS weekly wage, pay grew 3.9% a year against inflation of 3.0% over 2019-2021, the last year BLS publishes for this industry. Full analysis available in report.
Who are the major players in the Pharmacies and drug stores industry?
The industry spans 41.8K establishments (Census CBP, 2023) and carries a Moderate size label, so the typical location is neither very small nor very large. Full analysis available in report.
Get complete answers with detailed growth rates, forecasts, and competitive analysis.
Methodology
Every figure in this report is official US government data, computed in code and checked against the source by an automated validation pass. The text is drafted with AI, then read, reviewed and corrected where needed by a person. How we use AI
The Census Bureau's County Business Patterns and Economic Census provide establishment counts, employment, and payroll broken out by NAICS industry and geography. The Bureau of Labor Statistics QCEW program supplies wage data by industry. The Federal Reserve Economic Data (FRED) service contributes macroeconomic indicators used for industry forecasting — GDP, interest rates, housing starts, and sector-specific indices.
Data freshness varies by source: Census CBP has a ~2 year lag, BLS lags 6-9 months, and FRED provides near real-time macroeconomic data. Each report includes a data currency section showing exact year ranges.
Read our full methodology →Data Sources
Every chart, table, and claim in this report traces back to a published federal statistical database. Each data point in the PDF shows its source so you can verify it against the original dataset.
- U.S. Census Bureau — County Business Patterns & Economic Census
- Bureau of Labor Statistics — QCEW
- Federal Reserve Economic Data (FRED)
- SEC EDGAR — 10-K filings(Standard tier)
Report Details
Industry Classification (NAICS)
Where this industry sits in the North American Industry Classification System.
Classified on NAICS 2017. In NAICS 2022 this is part of 45611, “Pharmacies and Drug Retailers”, which is broader.
Related Industries
Related Guides
Get verified pharmacy industry trends data from federal sources. US Pharmacy & Drug Store Employment: 691K+ (Census CBP, 2023).
Get verified pharmacy profit margins data from federal sources. Typical Pharmacy Net Profit Margin: 2–4% (Industry Benchmarks, 2025).
Get verified retail industry trends data from federal sources. Total US Retail Employment: 15.5M (BLS Current Employment Statistics, April 2026).
Get verified retail profit margins data from federal sources. Average Retail Net Profit Margin: 2–5% (Industry Benchmarks, 2024).
Get verified car dealership industry trends data from federal sources. US New Car Dealer Employment: 1.1M+ (Census CBP, 2023).